FIELD: medicine. SUBSTANCE: agent has amino acid glycine or its pharmaceutically acceptable salts at quantity 0.1-0.2 mg per a dose and acceptable carrier. Agent is used sublingually at the dose 1-2 mg/kg mass, 2-3 times per a day for 14-30 days. EFFECT: increased effectiveness of agent. 5 cl, 22 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL PREPARATION SHOWING ANTIALCOHOLIC AND NOOTROPIC EFFECTS | 1995 |
|
RU2097034C1 |
| PHARMACEUTICAL ANTIALCOHOLIC COMPOSITION STIMULATING ENERGY METABOLISM, SECRETORY FUNCTION OF GASTRIC MUCOUS MEMBRANE AND PRODUCING HALIOPROTECTIVE AND ANTITUMOR EFFECT; METHOD OF PREVENTION AND TREATMENT OF ALCOHOLIC INTOXICATION AND ALCOHOLIC ABSTINENCE SYNDROME; METHOD FOR STIMULATING ENERGY METABOLISM; METHOD FOR STIMULATING AND DIAGNOSING ACID-FORMING AND SECRETORY FUNCTIONS OF GASTRIC MUCOSA; METHOD FOR PROTECTING WARM-BLOODED ANIMALS FROM RADIATION INJURY | 1993 |
|
RU2039556C1 |
| DISODIUM SALT OF SALICYLURIC ACID, POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2570644C1 |
| PHARMACEUTICAL COMPOSITION INDUCING GLUTATHIONE BIOSYNTHESIS, GLUTATHIONE TRANSFERASE ACTIVITY AND SHOWING ANTITOXIC, RADIOPROTECTIVE AND ANTIHYPOXIC ACTION AND METHODS OF TREATMENT, PROPHYLAXIS AND PROTECTION USING THEREOF | 1994 |
|
RU2096034C1 |
| POTASSIUM N-(4-ACETOXYBENZOYL)GLYCINATE POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2556637C1 |
| WATER-SOLUBLE SALICYL MORPHOLIDE POSSESSING NOOTROPIC ACTIVITY IN COMBINATION WITH ANTIDEPRESSANT ACTION | 2012 |
|
RU2495032C1 |
| CEREBRAL PROTECTIVE AND STRESS-PROTECTIVE MEDICINAL AGENT "NOOTRIL" AS INJECTION SOLUTION | 2003 |
|
RU2268711C2 |
| DISODIUM SALT OF 3-HYDROXYHIPPURIC ACID, HAVING ANTIHYPOXIC AND CEREBROPROTECTIVE ACTION | 2014 |
|
RU2559875C1 |
| 9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
| GAMMA-AMINOBUTYRIC ACID DERIVATIVE, HAVING NOOTROPIC ACTIVITY COUPLED WITH TRANQUILISING ACTIVITY | 2012 |
|
RU2495866C1 |
